Related by context. All words. (Click for frequent words.) 70 CCX# B 69 Hsp# Inhibitor 69 Meets Primary Endpoint 69 JAK inhibitor 69 Belimumab 68 diarrhea predominant irritable 68 Epratuzumab 68 oral dual endothelin 68 IBS C 68 developing Bicifadine serotonin 68 familial amyloidotic polyneuropathy FAP 68 Aflibercept 68 Traficet EN 68 HCV NS5B polymerase 68 vapreotide acetate 68 oral prodrug 68 CYT# potent vascular disrupting 68 metaglidasen 67 somatostatin analog 67 Pharmacokinetics PK 67 Zenvia ™ 67 DEB# 67 pseudobulbar affect PBA 67 PKC# 67 constipation predominant irritable bowel 67 PEGylated Fab fragment 67 acetonide FA 67 HQK 67 relapsing multiple sclerosis 67 ACTEMRA TM 67 class mGluR5 inhibitor 67 visilizumab 67 mGluR2 positive 66 BCG refractory carcinoma 66 constipation OIC 66 Zorbtive TM 66 Glufosfamide 66 topical gel formulation 66 GW# [003] 66 proteasome inhibitor 66 FOLFOX6 chemotherapy regimen 66 Etanercept 66 Pimavanserin 66 Luteinizing Hormone Releasing Hormone 66 Silodosin 66 dextromethorphan quinidine 66 Ceflatonin R 66 Golimumab 66 Maribavir 66 Linaclotide 66 diabetic neuropathic pain 66 oral dihydropyrimidine dehydrogenase DPD 66 6R BH4 66 TNF Tumor Necrosis Factor 66 Bosutinib 66 Methylnaltrexone 66 prokinetic agent 66 Vidofludimus 66 dasatinib Sprycel ® 66 IMiDs ® 66 BENLYSTA TM 66 Annamycin 66 PEGINTRON TM 66 allosteric modulator PAM 66 Triapine 66 fosbretabulin 66 Oral Fingolimod 66 Cethrin R 66 receptor tyrosine kinase inhibitor 65 Microplasmin 65 severe gastroparesis 65 selective antagonist 65 brand ciclesonide HFA 65 INSPIRE Trial Phase III 65 Daclizumab 65 MKC# MKC# PP 65 erlotinib Tarceva R 65 LymphoStat B belimumab 65 R lenalidomide 65 evaluating tivozanib 65 erlotinib Tarceva ® 65 IMiD 65 DDP# 65 Investigational Treatment 65 Plaque Psoriasis 65 Zoraxel TM 65 Interferon alfa 2b 65 investigational pharmacologically unique 65 either acutely decompensated 65 Mipomersen 65 Phase Ib clinical 65 PEG interferon 65 Carfilzomib 65 alpha 2b 65 Archexin 65 riociguat 65 Vildagliptin 65 Desvenlafaxine 65 sodium glucose cotransporter 65 serotonin norepinephrine reuptake inhibitor 65 peripherally acting 65 Zoraxel 65 Initiates Phase II 65 XL# anticancer compounds 65 refractory NSCLC 65 Tanespimycin 65 Aliskiren 65 KRN# 65 beta 1a 65 Mg Usa 65 acyclovir Lauriad R 65 myelodysplastic myeloproliferative diseases 65 methylnaltrexone bromide 65 nucleoside analog 65 infectious diseases autoimmune 65 Blinatumomab 65 Teriflunomide 65 cell lymphoma CTCL 65 pregabalin Lyrica 65 vinca alkaloid 65 Initiates Phase III 65 BRIM2 65 MTP inhibitor 65 Randomized Double blind 65 II Clinical Trial 65 neurogenic orthostatic hypotension 65 SinuNase TM 65 AA Amyloidosis 65 AKT inhibitor 65 Tocilizumab 65 Actonel risedronate 65 delivers fluocinolone acetonide FA 65 angiotensin receptor blocker ARB 64 PRN FDA Approves 64 constipation IBS C 64 Xanafide 64 Pafuramidine 64 Denufosol 64 sorafenib Nexavar 64 Voreloxin 64 Ziprasidone 64 MAGE A3 ASCI 64 phase IIa clinical 64 Factor VIIa 64 oral antiviral 64 non nucleoside inhibitor 64 orally inhaled migraine 64 INTEGRILIN R 64 formerly LymphoStat B 64 HMG CoA reductase inhibitors 64 tizanidine hydrochloride short 64 Fx #A 64 IAP inhibitor 64 Dementia Related Psychosis 64 vitreoretinal disorders 64 YONDELIS 64 investigational humanized monoclonal antibody 64 Granted Orphan Drug 64 PDE4 inhibitor 64 phase IIb clinical 64 polymerase inhibitor 64 PEGylated anti 64 HSP# inhibitor 64 Oracea TM 64 Initiate Phase 64 alfa 2a 64 Initiates Enrollment 64 virus HCV protease inhibitor 64 Sapacitabine 64 Perforomist ™ Inhalation Solution 64 ADP receptor antagonist 64 Ocrelizumab 64 HGS ETR1 mapatumumab 64 oral nucleoside analogue 64 intranasal formulation 64 IMiDs R 64 SPRYCEL ® 64 Lixivaptan 64 RhuDex 64 Novel Oral 64 Panzem R 64 thalidomide Thalomid 64 XL# XL# 64 forodesine hydrochloride 64 INCB# [003] 64 CEQ# 64 plus prednisone prednisolone 64 Romiplostim 64 Phase Ib IIa 64 endothelin receptor antagonists 64 Rheumatoid Arthritis RA 64 Ustekinumab 64 FDA APPROVES 64 docetaxel Taxotere ® 64 inflammatory PDE 64 humanized interleukin 6 64 infectious diseases autoimmune diseases 64 canakinumab 64 CIMZIA TM certolizumab pegol 64 LEVADEX TM 64 Dasatinib 64 gastrointestinal disorders ATI 64 R Saizen R 64 Adalimumab 64 adalimumab Humira 64 memantine HCl 64 advanced metastatic renal 64 docetaxel Taxotere R 64 Lenalidomide 64 hypoxia activated prodrug 64 IMiDs ® compound 64 Receives Orphan Drug Designation 64 pan HDAC inhibitor 64 Cannabinor 64 Xeloda ® 63 cannabinor 63 CIMZIA R 63 ocular formulation 63 Dyloject TM 63 Vicriviroc 63 somatostatin analogue 63 AAG geldanamycin analog 63 Multiple Ascending Dose 63 Aryplase 63 Ambrisentan 63 velafermin 63 PNP inhibitor 63 Crofelemer budesonide foam 63 post herpetic neuralgia PHN 63 CIMZIA ™ 63 Ophena TM 63 Tezampanel 63 SCH # 63 NS5B polymerase 63 Randomized Phase 63 CorVue ™ 63 dyskinesia PD LID 63 delta gamma agonist 63 Omacetaxine 63 interferon alpha IFN alpha 63 Rilonacept 63 levetiracetam Keppra 63 Double Blind Placebo 63 relapsed MM 63 Dapagliflozin 63 subcutaneously administered 63 ISTODAX ® 63 GSK# [001] 63 baminercept 63 beta2 agonist 63 rilonacept 63 small molecule Hedgehog 63 Long Term Efficacy 63 Patients Treated With 63 Liprotamase 63 mild vasodilator 63 antibody MAb 63 Antitumor Activity 63 PHX# 63 EOquin TM phase 63 sorafenib tablets 63 systemic juvenile idiopathic 63 Milnacipran 63 ® lenalidomide 63 refractory chronic lymphocytic 63 OMAPRO ™ 63 Ozarelix 63 Anidulafungin 63 Pegloticase 63 Dalbavancin 63 undergoing elective percutaneous 63 PDX pralatrexate 63 aflibercept VEGF Trap 63 Elagolix 63 Myelofibrosis 63 active ankylosing spondylitis 63 Complicated Skin 63 CCR5 antagonist 63 selective androgen receptor modulator 63 Deforolimus 63 depressive episodes associated 63 Simulect 63 serologically active systemic lupus 63 rheumatoid arthritis psoriatic arthritis 63 Copegus ® 63 Phase IIa clinical 63 TELINTRA 63 Bucindolol 63 dasatinib Sprycel 63 RoACTEMRA 63 opioid naive 63 Completes Patient Enrollment 63 Pradefovir 63 CCR9 antagonist 63 Paliperidone ER 63 BLyS specific 63 5 HT6 receptor 63 5 HT2A inverse 63 denileukin diftitox 63 painful diabetic neuropathy 63 mu opioid receptor antagonist 63 miconazole Lauriad ® 63 Certolizumab pegol 63 refractory gout 63 JAK2 Inhibitor 63 Pivotal Phase III 63 teriflunomide 63 Romidepsin 63 Drug Candidate 63 Talabostat 63 PRT# 63 compound INCB# 63 LymphoStat B TM 63 selective modulator 63 FUSILEV enhances 63 Bortezomib 63 melanocortin receptor agonists 63 dutogliptin 63 Ceftaroline 63 Major Depressive Disorder MDD 63 relapsed multiple myeloma 63 cetuximab Erbitux R 63 Kuvan sapropterin dihydrochloride 63 Phase IIb Trial 63 BRILINTA 63 TO AVOID PREGNANCY WHILE 63 tocilizumab 63 CD# monoclonal antibody 63 selective kinase inhibitor 63 Prolongs Survival 63 ritonavir boosted 63 5 HT3 antagonist 63 lintuzumab SGN 63 MERREM 63 pegylated interferons 63 Vidaza azacitidine 63 albiglutide 63 First Patient Dosed 63 nilotinib Tasigna ® 63 By JENNIFER LEARN 63 Temsirolimus 63 Hypoactive Sexual Desire Disorder 63 immunotherapeutic agent 62 AEG# 62 orally administered inhibitor 62 ALVESCO ® 62 RH1 62 relapsed leukemia 62 Oral NKTR 62 Entereg R 62 Peginterferon alfa 2b 62 Plicera 62 Fludarabine 62 Phase 2b Clinical Trial 62 nilotinib Tasigna 62 receptor partial agonist 62 Remicade infliximab 62 Safinamide 62 RhuDex ® 62 oral proteasome inhibitor 62 VICTOR E3 62 Tolvaptan 62 Elotuzumab 62 novel histone deacetylase 62 PD LID 62 unique alkylating agent 62 Pagoclone 62 HYVISC ® treatment 62 Relapsed Refractory 62 Pertuzumab 62 Paliperidone Palmitate 62 generation Hsp# inhibitor 62 RNA antagonists 62 AVASTIN 62 Gleevec imatinib mesylate 62 histone deacetylase HDAC inhibitor 62 HuMax CD4 62 lenalidomide Revlimid R 62 CTA# Injection 62 small molecule thrombopoietin 62 alvespimycin 62 sapacitabine CYC# 62 Ticagrelor 62 Proxinium TM 62 HCV Protease Inhibitor 62 imatinib Gleevec ® 62 OncoVEX GM CSF 62 Tibotec Therapeutics division 62 ALVESCO R 62 relapsing remitting MS RRMS 62 IMA# 62 Kahalalide F 62 Thiazolidinediones 62 vascular disrupting agent 62 Phase IIb Clinical Trial 62 adenosine A2A 62 Squalamine 62 placebo controlled clinical 62 Epothilones 62 DORIBAX 62 Amgen Neulasta R 62 Fingolimod 62 Study Evaluating 62 Arimoclomol 62 cutaneous T 62 reslizumab 62 Medoxomil 62 CYP#A# CYP#D# 62 HCV RNA polymerase 62 Tasimelteon 62 SUTENT ® 62 CDP# 62 selective A2A adenosine receptor 62 Fludara ® 62 included exfoliative dermatitis 62 Syndrome LEMS 62 Dose Escalation 62 HDAC Inhibitor 62 relapsed refractory multiple myeloma 62 Pazopanib 62 vascular occlusive diseases 62 icatibant 62 Kuvan R 62 volociximab 62 Diabetic Neuropathy 62 pathophysiological effects 62 CCX# 62 Recurrent Glioblastoma 62 Mg Uk 62 acadesine 62 orally bioavailable 62 highly selective endothelin 62 Pharmacokinetic Study 62 Fibrillex TM 62 overactive bladder syndrome 62 Myelodysplastic Syndrome MDS 62 Clofarabine 62 Guanilib 62 Inhalation Aerosol 62 Lubiprostone 62 label Lipofen R 62 midstage clinical 62 hypereosinophilic syndrome 62 Teva Provides Update 62 Humira adalimumab 62 Serdaxin ® 62 Enzyme Replacement Therapy 62 Warfarin Coumadin 62 Aclidinium 62 GSK# [002] 62 anti muscarinic 62 ENMD # 62 novel oral anticoagulant 62 Lambert Eaton Myasthenic 62 Placebo controlled 62 Olaparib 62 Nilotinib 62 Anti Tumor 62 candidates Azedra TM 62 Neurodex 62 ZOLINZA 62 folate analogue metabolic 62 rhIGF-I/rhIGFBP-3 62 prucalopride 62 subcutaneous formulation 62 Tyrima 62 Vascugel 62 PF # [002] 62 CTAP# Capsules 62 echinocandin 62 sunitinib malate 62 ALN HPN 62 vinorelbine tartrate 62 superficial bladder cancer 62 Granulocyte Colony Stimulating Factor 62 galiximab 62 TRANSDUR ® 62 LEVAQUIN ® 62 Delafloxacin 62 Ovitrelle R Serostim 62 Xyrem ® 62 BAL# [002] 62 Eraxis 62 injectable formulation 62 BENLYSTA ® 62 Febuxostat 62 ACZ# 62 LibiGel ® 62 Otelixizumab 62 use transdermal sumatriptan 62 rivastigmine Exelon 62 metformin sulfonylurea 62 lomitapide 62 RE MODEL 62 RAPAFLO 62 Abatacept 62 sunitinib Sutent ® 62 oral ghrelin agonist 62 interferon gamma 1b 62 trastuzumab Herceptin R 62 Argatroban 62 essential thrombocythemia ET 62 Eculizumab 62 Sodium oxybate 62 oral Janus kinase 62 Glatiramer Acetate 62 carcinoid syndrome 62 Ridaforolimus 62 Pivotal Phase II 62 IMiDs 62 LAB CGRP 62 Risperidone 62 CIMZIA TM 62 leukemia AML 62 sertraline Zoloft 62 VAPRISOL 62 Ixabepilone 62 opioid induced bowel dysfunction 62 HuMax EGFr 62 SPL# Gel vaginal microbicide 62 ZYBRESTAT fosbretabulin 62 Tesamorelin 62 selective androgen receptor modulators 61 IMPDH inhibitor 61 lumiliximab 61 Tumor Necrosis Factor 61 BAY #-# 61 Pralatrexate 61 davunetide intranasal AL 61 Desvenlafaxine Succinate 61 endothelin receptor 61 Androxal TM 61 recurrent glioblastoma multiforme 61 Medidur TM FA 61 ankylosing spondylitis psoriatic arthritis 61 octreotide acetate 61 Unit Dose Budesonide 61 Aurora Kinase 61 Zalypsis 61 Mylan Receives Approval 61 humanized therapeutic 61 Amrubicin 61 thiazolides 61 Onalta 61 injectable enzyme 61 Phase 1b clinical 61 rheumatoid arthritis osteoarthritis ankylosing 61 Enzastaurin 61 Tofacitinib 61 Liposomal 61 Novolimus 61 chronic eosinophilic leukemia 61 Bafetinib 61 Aviptadil 61 highly selective inhibitor 61 herpetic keratitis 61 XL# XL# XL# 61 Cimzia certolizumab pegol 61 Darusentan 61 oral talactoferrin 61 Lamotrigine 61 Refractory Angina 61 tyrosine kinase inhibitor TKI 61 Valsartan 61 Solzira TM 61 novel topoisomerase 61 TRANSDUR ™ 61 MEK inhibitors 61 PRTX 61 efalizumab 61 PEGylated interferon beta 1a 61 Imatinib mesylate 61 Tyrosine Kinase Inhibitor 61 valtorcitabine 61 Phase III Clinical Trial 61 RezularTM 61 Budesonide foam crofelemer 61 novel VDA molecule 61 Cariprazine 61 REMINYL ® 61 Mirapexin 61 oral rivaroxaban 61 post herpetic 61 ALN TTR# 61 dirucotide MBP# 61 novel immunomodulatory 61 generation purine nucleoside 61 chronic idiopathic thrombocytopenic purpura 61 Novel Antibiotic 61 sitagliptin metformin 61 terlipressin 61 tiapamil 61 RhuDex TM 61 Receives Fast Track 61 Epidermal Growth Factor Receptor 61 Cethromycin 61 COPEGUS R 61 First Patient Enrolled 61 small molecule chemotherapeutic 61 ropinirole Requip 61 invasive candidiasis 61 Bazedoxifene 61 cancer neuroendocrine tumor 61 AVONEX ® 61 Frozen Shoulder Syndrome 61 elotuzumab 61 Investigational Drug 61 Orally Active 61 Levaquin levofloxacin 61 opioid bowel dysfunction 61 hypomethylating agents 61 Raptiva ® 61 dose escalation clinical 61 5 FU leucovorin 61 pegylated interferon alpha 2a 61 R rilonacept Injection 61 Fondaparinux 61 Phase #b/#a clinical 61 neuro inflammatory disorders 61 antiplatelet agent 61 regorafenib 61 Pemetrexed 61 TRIOLEX HE# APOPTONE HE# 61 venlafaxine Effexor 61 HCD# [002] 61 topically applied SEPA 61 refractory CLL 61 NMDA antagonist 61 TMC# C# 61 Pirfenidone 61 Atripla combines 61 BMS # 61 nonsteroidal 61 Malignant Glioma 61 oncolytic virus therapies 61 Synta Announces 61 RhuDex R 61 Newly Diagnosed Multiple Myeloma 61 potent topoisomerase II 61 Relapsing Multiple Sclerosis 61 targeted radiotherapeutic 61 TACI Ig 61 Hedgehog Pathway Inhibitor 61 idiopathic Parkinson disease 61 investigational monoclonal antibody 61 treat benign prostatic 61 Catena ® 61 APTIVUS r 61 liposomal formulation 61 prednisone prednisolone plus 61 eosinophilic asthma 61 Tiotropium 61 Personalized Immunotherapy 61 Degarelix 61 D aspartate NMDA receptor 61 aripiprazole Abilify 61 Aeolus Pharmaceuticals Announces 61 psoriasis rheumatoid arthritis 61 XL# XL# XL# XL# 61 pediatric Crohn disease 61 Phase IIa Clinical Trial 61 Dacogen injection 61 Oral Spray 61 Natalizumab 61 CALGB # [002] 61 CINQUIL 61 Combination REOLYSIN R 61 Investigational Compound 61 AGILECT R 61 Demonstrates Significant 61 gastrin analogue TT 61 Demonstrates Positive 61 2 methoxyestradiol 61 BCR ABL inhibitor 61 Naive Patients 61 fibromyalgia syndrome 61 SUSTENNA TM 61 kidney urologic 61 Panzem R NCD 61 tafamidis 61 Interferon beta 61 Carbamazepine 61 Namenda Memantine HCl 61 CB2 selective receptor agonist 61 Sycrest 61 HGS# 61 hormone LHRH antagonist 61 gemcitabine Gemzar ® 61 Zemplar Capsules 61 mitoxantrone plus 61 Lupus Nephritis 61 postoperative ileus POI 61 oxypurinol 61 Rotigotine 61 Phase III multicenter 61 Vidaza ® 61 Modrenal R 61 Zileuton 61 Xcytrin R 61 ATL# [001] 61 Val HeFT 61 alemtuzumab Campath 61 PPAR gamma agonist 61 SomatoKine 61 metformin HCl 61 Diabetic Macular Edema 61 Genasense ® 61 Fc fusion protein 61 retinal vein occlusion induced 61 LAS# [002] 61 non thiazolidinedione TZD 61 Phase 1a clinical 61 GSK '# 61 mTOR inhibitor 61 paliperidone palmitate 61 Submits NDA 61 Castration Resistant Prostate Cancer 61 OHR/AVR# 61 IFN α 61 alpha 2A 61 TRO# 61 includes AstraZeneca Accolate 61 HIV integrase inhibitor 61 pharmacokinetic PK study 61 humanised monoclonal antibody 61 recurrent metastatic ovarian cancer 61 octreotide implant 61 Bremelanotide 61 Idiopathic Pulmonary Fibrosis 61 vaginal candidiasis 61 epothilones 61 MKC# MT 61 transthyretin TTR mediated amyloidosis 61 dexlansoprazole 61 systemic fungal infections 61 zanolimumab 61 Eniluracil 61 Tipranavir 61 Monotherapy 61 BoNTA 61 severe hypercholesterolemia 61 de novo kidney transplant 61 agent VDA 61 Intervention Effectiveness 61 bevacizumab Avastin ® 61 Trial Evaluating 61 mTOR mammalian target 61 telomerase therapeutic 61 peritumoral brain edema 61 Sanvar R 61 Vertex hepatitis C 61 Debio 61 Launches Generic Version 61 clinical trials Archexin ® 61 ULORIC 61 MEK inhibitor 61 bosutinib 61 antidepressants fluoxetine 61 infliximab monotherapy 61 Vilazodone 61 phase III isavuconazole 61 cortisol synthesis 61 Crizotinib PF # 61 NVA# 61 Sudhir Agrawal D.Phil 60 IV Busulfex 60 Seliciclib 60 Phase 2b clinical trials 60 humanized anti 60 desvenlafaxine 60 Teplizumab 60 huN# DM1 60 CANCIDAS 60 R sorafenib tablets 60 TLK# 60 Vitrasert R 60 ELADUR ™ 60 EDEMA3 trial 60 Rivaroxaban 60 Prospective Randomized 60 Albuferon TM 60 oropharyngeal candidiasis 60 Initiated Phase 60 Demonstrates Efficacy 60 nucleoside analogue 60 post operative ileus 60 Simponi golimumab 60 LEVAQUIN 60 small molecule glucokinase 60 plus prednisone 60 humanized monoclonal antibody 60 evaluating carfilzomib 60 Tesetaxel 60 Bicifadine 60 BCR ABL inhibitors 60 KIACTA ™ 60 BYETTA ® 60 Preclinical studies suggest 60 hypertrichosis occurred 60 markets HP Acthar 60 PROVENGE ® 60 opioid induced constipation OIC 60 reversible inhibitors 60 M# rationally 60 Hospital Acquired Pneumonia 60 SARMs 60 Phase III confirmatory 60 Alemtuzumab 60 bone marrow reticulin deposition 60 Ostarine ™ 60 TAFA# 60 Congenital Emphysema 60 inhalation powder 60 STELARA TM 60 Darunavir 60 BRAF inhibitor 60 Vernakalant 60 statin HMG CoA reductase 60 PHASE III 60 esomeprazole Nexium 60 Resten NG 60 MOVIPREP R 60 ACTIQ ® 60 monoclonal antibody MAb 60 receptor modulators 60 NOXAFIL 60 sapropterin dihydrochloride 60 NOTE POSIDUR ™ 60 HCV polymerase inhibitors 60 Cinacalcet 60 alefacept 60 Laquinimod 60 Pooled Analysis 60 DNA methyltransferase inhibitors 60 transcriptase inhibitor NNRTI 60 NR2B selective 60 Janus Kinase 60 Heterozygous Familial Hypercholesterolemia 60 Saxagliptin 60 boosted protease inhibitor 60 fipamezole 60 JAK Inhibitor 60 Pivotal Phase 60 Angiotensin Converting Enzyme 60 Tesmilifene 60 Pulmonary Arterial Hypertension 60 olanzapine Zyprexa 60 pancreatic enzyme replacement 60 Darinaparsin 60 interleukin IL -# 60 Raptiva r 60 Ceflatonin 60 cladribine Cladribine Tablets 60 Adjunctive 60 headache abdominal pain 60 Vascular Disrupting Agent 60 Previously Treated 60 ficlatuzumab 60 anti inflammatory NSAID 60 toenail onychomycosis 60 risedronate sodium tablets 60 Dose Ranging Study 60 LEUKINE 60 Remission Maintenance 60 calcitonin gene related 60 entinostat 60 non peptidic protease 60 Solesta 60 Indaflex TM 60 Pyridorin 60 Mantle Cell Lymphoma 60 Firdapse TM amifampridine phosphate 60 Elesclomol 60 diabetic peripheral neuropathic DPN 60 OvaRex ® MAb 60 LAF# 60 long acting muscarinic 60 thiazolidinedione TZD 60 Betaferon R 60 ganetespib 60 R adalimumab 60 TKB# 60 IAP inhibitors 60 MabThera rituximab 60 NAVISTAR R 60 Peginterferon Alfa 2a 60 Aganocide 60 mapatumumab 60 Spiegelmer ® 60 GOUT 60 anti arrhythmic drug 60 Fluvastatin 60 Amgen Enbrel 60 TNF antagonist 60 romidepsin 60 briakinumab 60 autoimmune uveitis 60 PrevOnco 60 idiopathic thrombocytopenic purpura ITP 60 Roche Actemra 60 Rigel R# 60 dextofisopam 60 GI motility disorders 60 Orally administered 60 IRX 2 60 reuptake inhibitor 60 analgesic efficacy 60 clobazam 60 Solorel TM 60 LEVADEX ™ 60 Thiarabine 60 Albugon 60 noninfectious uveitis 60 Clolar ® 60 TBC# 60 patients coinfected 60 Phase #/#a 60 immunomodulatory therapy 60 Noxafil 60 Ofatumumab 60 xanthine oxidase inhibitor 60 administered subcutaneously 60 novel nucleoside analog 60 protein tyrosine phosphatase 1B 60 Randomized Double Blind 60 Pruvel TM 60 phase IIIb 60 etanercept Enbrel 60 Lacosamide 60 Targretin 60 cathepsin K inhibitor 60 nucleotide analogue 60 investigational atypical antipsychotic 60 Gel repository corticotropin injection 60 seliciclib CYC# 60 HepeX B TM 60 Ranibizumab 60 anti amnesic 60 Lomitapide 60 REVLIMID lenalidomide 60 refractory unresponsive 60 neuropathic pain metabolic diseases 60 Bezielle 60 CYP#A# isoenzyme 60 AVAPRO 60 NP2 Enkephalin 60 mycophenolate mofetil 60 Bavituximab 60 lucinactant 60 gastro intestinal inflammation 60 Phase 2a clinical 60 selective adhesion molecule 60 rasagiline tablets 60 cirrhotic CHC monoinfected patients 60 psoriasis psoriatic arthritis 60 pan histone deacetylase 60 tasocitinib 60 Biogen Genentech 60 R#/MEM # 60 ASM8 60 Factor Xa inhibitor 60 non splenectomized 60 p# inhibitor 60 combines bupropion 60 decitabine 60 Piperacillin 60 FOLOTYN ® 60 subtype selective NMDA receptor 60 CIPN 60 BARACLUDE ® 60 certolizumab 60 Valdoxan 60 Doripenem 60 opioid receptor antagonist 60 diabetic gastroparesis 60 antifibrotic 60 GRNOPC1 contains 60 Rebif ® 60 dihydrochloride Tablets 60 candidate Zenvia 60 Kamada AAT 60 dual endothelin receptor antagonist 60 Exelixis compounds 60 demonstrated antitumor activity 60 abiraterone acetate 60 Alinia 60 DPP4 inhibitor 60 Randomised 60 Phase Ib clinical trials 60 gastrointestinal GI motility disorders 60 CA4P 60 tenofovir emtricitabine 60 Cloretazine 60 Angiotensin converting enzyme ACE 60 MT# MEDI 60 Kinase Inhibitor 60 dose escalation phase 60 * olmesartan medoxomil 60 Clevudine